Top Vaccines companies in United States by Capital Expenditure

This ranking features the top 17 Vaccines companies in United States ranked by Capital Expenditure, totalling a Capital Expenditure of USD -1.62 B, for January 15, 2025.
#
Name
Capital Expenditure
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD -749.00 M
Sept. 30, 2024 USD 34.46 -1.96%

United States

2
USD -637.00 M
Sept. 30, 2024 USD 164.41 -1.15%

United States

3
USD -152.59 M
Sept. 30, 2024 USD 78.14 -3.73%

United States

4
USD -20.20 M
Sept. 30, 2024 USD 8.51 -1.16%

United States

5
USD -16.48 M
Sept. 30, 2024 USD 1.97 -1.50%

United States

6
USD -12.73 M
Sept. 30, 2024 USD 2.32 -6.45%

United States

7
USD -6.88 M
Sept. 30, 2024 USD 16.32 -1.03%

United States

8
USD -6.43 M
Sept. 30, 2024 USD 10.23 -2.76%

United States

9
USD -6.40 M
Sept. 30, 2024 USD 9.38 -6.57%

United States

10
USD -4.60 M
Sept. 30, 2024 USD 12.48 NA

United States

11
USD -2.38 M
June 30, 2024 USD 16.59 -4.16%

United States

12
USD -1.14 M
Sept. 30, 2023 USD 3.18 -5.08%

United States

13
USD -995.00 K
Sept. 30, 2024 USD 4.69 -4.29%

United States

14
USD -614.00 K
Sept. 30, 2024 USD 1.86 4.49%

United States

15
USD -200.00 K
Sept. 30, 2024 USD 12.31 -23.96%

United States

16
USD 0.00
July 31, 2024 USD 2.13 -2.74%

United States

17
USD 0.00
Sept. 30, 2024 USD 5.96 -8.87%

United States

Frequently Asked Questions
  • Which Vaccines company in United States has the highest Capital Expenditure ?

    The Vaccines company in United States with the highest Capital Expenditure is Moderna, Inc. (NasdaqGS: MRNA) at USD -749.00 M.

  • Which Vaccines company in United States has the lowest Capital Expenditure ?

    The Vaccines company in United States with the lowest Capital Expenditure is INmune Bio, Inc. (NasdaqCM: INMB) at USD 0.00.